Ligand Pharmaceuticals Incorporated (LGND) Profit Margins
Over the twelve months to 2026-06-30, Ligand Pharmaceuticals Incorporated (LGND) had operating margin 32.6%, net margin 67.9%, free cash flow margin 45.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LGNDLigand Pharmaceuticals IncorporatedFollow LGND — free
—
Price chart with a free account
- Market cap
- 6.1B
- P/E TTM
- 32.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 83.7% | 88.5% | 88.3% | 85.8% | 91.9% | 94.9% | 96.2% | 97.5% | — | — | — | — | — | — | — | — | |
| Operating margin | -2.9% | 0.6% | 30.5% | 30.4% | 38.0% | 40.3% | 48.2% | 65.1% | 671.0% | 22.9% | 43.0% | 1.5% | 9.1% | -13.5% | 15.3% | 32.6% | |
| Net margin | 32.3% | -1.7% | 23.3% | 18.6% | 319.6% | -1.5% | 8.9% | 57.0% | 523.2% | -1.8% | 23.7% | -17.0% | 39.7% | -2.4% | 46.4% | 67.9% | |
| FCF margin | -4.2% | -1.4% | 41.5% | 31.9% | 57.9% | 54.0% | 61.2% | 76.8% | -26.5% | 30.6% | 29.0% | 61.1% | 35.1% | 57.0% | 18.2% | 45.2% |
USD billions · SEC XBRL
Ligand Pharmaceuticals Incorporated — questions
- What is Ligand Pharmaceuticals Incorporated's operating margin?
- 32.6% over the twelve months to 2026-06-30.
- What is Ligand Pharmaceuticals Incorporated's net profit margin?
- 67.9% over the twelve months to 2026-06-30.
Every figure on this page comes from Ligand Pharmaceuticals Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.